Cardiac lesions induced by chemicals.
Chemically induced cardiomyopathies are frequently the consequences of a cardiac metabolic imbalance brought about by exaggerated functional affects. The infarctlike lesions induced by adrenergic beta-receptor stimulants and the vasodilating antihypertensives serve as examples of this phenomenon. Direct cardiotoxic mechanisms not related to cardiovascular functional effects are responsible for another class of toxic cardiomyopathy. An example of this is the cardiomyopathy produced by the anthracycline antineoplastic agents. The pathogenesis, morphological changes and toxicologic features of these cardiomyopathies are described with particular reference to their detection in preclinical toxicity studies.
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000009:adverse effects; D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects; D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology; D002319:Cardiovascular System / Q000187:drug effects; D002908:Chronic Disease; D003630:Daunorubicin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004353:Drug Evaluation, Preclinical; D006331:Heart Diseases / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D013045:Species Specificity
D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D004317:Doxorubicin; D003630:Daunorubicin